Why Perfect B Is Evaluating AOD 9604: Our Clinical Perspective We began our internal evaluation of AOD 9604 in response to a consistent pattern we were seeing with patients in our South Florida practice: people who had experienced meaningful fat loss on GLP-1 medications, then plateaued or discontinued due to side effects, and were looking for a next option
A single missed dose has minimal impact on overall results
For SQ injections, it also depends on where your body tends to carry more fat
Injecting in the wrong area can cause an abscess to form under the skin To avoid this only inject in the area recommended by your nurse or doctor
This synthetic piece of protein stimulates lipolysisthe breakdown and burning of stored and stubborn fatwithout affecting blood sugar, insulin sensitivity, or growth in nonfat tissues
IV hydration and vitamin injection therapies are intended to supplement not replace a balanced diet and appropriate medical care, and are not FDA-approved to treat any disease
